Sexual Behavior in Head and Neck Cancer Patients

NCT00662662 | Unknown

• 1 other identifier: 2007-0485
• Study Type: observational
• Target: 1,500
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this behavioral research study is to learn if certain sexual behaviors increase the risk for developing head and neck cancers associated with a virus called human papillomavirus (HPV-16). Knowing this information could help doctors better teach patients about avoiding certain risk factors, which may help to prevent the disease.

Conditions

Oropharyngeal Cancer; Head and Neck Cancer; Squamous Cell Carcinoma

Keywords

Oropharyngeal Cancer; Non-Oropharyngeal Cancer; Head and Neck Cancer; Squamous Cell Carcinoma; Squamous cell carcinoma of the head and neck; SCCHN; HPV-16; Questionnaire; Sexual Behavior; Survey

Outcome Measures

Primary Outcomes (1)

• To find out if certain sexual behaviors increase the risk for developing head and neck cancers associated with a virus called human papillomavirus (HPV-16).

  6 Years

Study Arms (2)

Oropharyngeal Cancer

Behavioral: Questionnaire

Non-Oropharyngeal Cancer

Behavioral: Questionnaire

Interventions

Questionnaire BEHAVIORAL

The questionnaire contains 18 questions and is estimated to take approximately 10-15 minutes to complete.

Non-Oropharyngeal Cancer; Oropharyngeal Cancer

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Approximately 600 oropharynx study participants and 900 non-oropharynx study participants.

You may qualify if:

• Patients with newly diagnosed, previously untreated squamous cell carcinoma of the head and neck (SCCHN) who are candidates for the molecular epidemiology study LAB00-062 of head and neck cancer.
• Must have the ability to understand and provide informed consent.
• Patients must be 18 years and older.
• Ability to read, write, and speak English.
• Resident of the United States.
• Agrees to have tumor tissue, if available, tested for HPV. No additional biopsy will be requested.

You may not qualify if:

• Previous cancer diagnosis excluding non-melanoma skin cancer.
• Blood transfusion within the previous 6 months.
• Immune suppression, such as HIV disease or immune-suppressing therapy (i.e., steroids).

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• University of Texas MD Anderson Cancer Center Website

MeSH Terms

Conditions

Oropharyngeal Neoplasms; Head and Neck Neoplasms; Carcinoma, Squamous Cell; Squamous Cell Carcinoma of Head and Neck; Sexual Behavior

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pharyngeal Neoplasms; Otorhinolaryngologic Neoplasms; Neoplasms by Site; Neoplasms; Pharyngeal Diseases; Stomatognathic Diseases; Otorhinolaryngologic Diseases; Carcinoma; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type; Neoplasms, Squamous Cell; Behavior

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Erich Sturgis, MD

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 17, 2008
• First Posted: April 21, 2008
• Study Start: April 1, 2008
• Primary Completion: May 31, 2022
• Study Completion: May 31, 2022
• Last Updated: December 30, 2020

Record last verified: 2020-12

Locations

US (1)